Myasthenic crisis in COVID-19

J Neurol Sci. 2020 Jul 15:414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.

Abstract

  1. Myasthenic crises is a potentially severe complication of COVID-19.

  2. Hydroxychloroquine can aggravate myasthenia crises.

  3. IVIg is a potential treatment for both Myasthenic crises and COVID-19.

  4. IVIg treatment may cause thrombosis in susceptible patients.

Keywords: COVID-19; Myasthenia; Viral infection.

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Humans
  • Lambert-Eaton Myasthenic Syndrome*
  • Myasthenia Gravis*
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2
  • Thymectomy